3-(4-(6-(5-(4-Methoxyphenyl)-1,3,4-oxadiazol-2-yl)-1H-benzo[d]imidazol-2-yl)-3,5-dimethylphenyl)-2,2-dimethylpropanoic Acid sodium

ID: ALA4098214

PubChem CID: 137661810

Max Phase: Preclinical

Molecular Formula: C29H28N4NaO4+

Molecular Weight: 496.57

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2nnc(-c3ccc4nc(-c5c(C)cc(CC(C)(C)C(=O)O)cc5C)[nH]c4c3)o2)cc1.[Na+]

Standard InChI:  InChI=1S/C29H28N4O4.Na/c1-16-12-18(15-29(3,4)28(34)35)13-17(2)24(16)25-30-22-11-8-20(14-23(22)31-25)27-33-32-26(37-27)19-6-9-21(36-5)10-7-19;/h6-14H,15H2,1-5H3,(H,30,31)(H,34,35);/q;+1

Standard InChI Key:  CDJLBSTYCHKNOF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 41  0  0  0  0  0  0  0  0999 V2000
   26.9564  -17.9599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9605  -17.1425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2505  -17.5476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7313  -16.4471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9830  -16.0548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5551  -16.0584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7547  -18.1224    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.9878  -16.8816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3833  -16.7374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0875  -17.8858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0768  -17.3181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3220  -17.1649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7679  -15.7948    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.4974  -17.1694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2350  -18.1587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2578  -16.4608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8390  -17.2983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5352  -17.5783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0831  -16.4559    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5633  -16.6503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9473  -18.2934    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.4868  -15.7405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4160  -18.0751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5540  -16.8862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3099  -15.7325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7756  -17.1326    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.2674  -15.6456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0670  -15.0298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2691  -17.2992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2559  -17.2322    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.7144  -17.4913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0879  -16.9653    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.9230  -16.4856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5487  -16.4412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7800  -17.1404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1939  -17.8455    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.1837  -16.4295    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.7419  -19.2481    0.0000 Na  0  0  0  0  0 15  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
 11 23  1  0
 23 15  2  0
 16 13  2  0
 11 30  1  0
 32 18  1  0
 15 31  1  0
 18 21  2  0
 27  6  1  0
 31  9  2  0
 22 19  1  0
 20 11  2  0
  6 24  2  0
  5  8  1  0
 14 10  1  0
 29  8  2  0
 14 12  1  0
 24 29  1  0
 16 19  1  0
 24 17  1  0
 17 32  1  0
 21  7  1  0
  4 25  1  0
  7 17  2  0
 26 16  1  0
  9 20  1  0
 19 14  2  0
 22 28  1  0
  5 27  2  0
  8 26  1  0
 12  4  2  0
 13  5  1  0
 25 22  2  0
 18 31  1  0
 30 33  1  0
  4 34  1  0
 34  2  1  0
  2 35  1  0
 35 36  1  0
 35 37  2  0
M  CHG  1  38   1
M  END

Associated Targets(non-human)

Plasma (810 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 496.57Molecular Weight (Monoisotopic): 496.2111AlogP: 6.23#Rotatable Bonds: 7
Polar Surface Area: 114.13Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 5.07CX Basic pKa: 4.42CX LogP: 5.82CX LogD: 3.85
Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.27Np Likeness Score: -0.51

References

1. Nakajima K, Chatelain R, Clairmont KB, Commerford R, Coppola GM, Daniels T, Forster CJ, Gilmore TA, Gong Y, Jain M, Kanter A, Kwak Y, Li J, Meyers CD, Neubert AD, Szklennik P, Tedesco V, Thompson J, Truong D, Yang Q, Hubbard BK, Serrano-Wu MH..  (2017)  Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans.,  60  (11): [PMID:28498655] [10.1021/acs.jmedchem.7b00173]

Source